Vir Biotechnology Stock (NASDAQ: VIR) stock price, news, charts, stock research, profile.
Open | $8.020 |
Close | $8.100 |
Volume / Avg. | 1.091M / 1.081M |
Day Range | 7.910 - 8.400 |
52 Wk Range | 7.720 - 27.480 |
Market Cap | $1.102B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 32 |
Short Interest | 5.97% |
Days to Cover | 5.99 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Vir Biotechnology (NASDAQ: VIR) through any online brokerage.
Other companies in Vir Biotechnology’s space includes: Macrogenics (NASDAQ:MGNX), Immunome (NASDAQ:IMNM), 4D Molecular Therapeutics (NASDAQ:FDMT), Zentalis Pharma (NASDAQ:ZNTL) and Centessa Pharmaceuticals (NASDAQ:CNTA).
The latest price target for Vir Biotechnology (NASDAQ: VIR) was reported by HC Wainwright & Co. on Friday, March 15, 2024. The analyst firm set a price target for 110.00 expecting VIR to rise to within 12 months (a possible 1256.35% upside). 15 analyst firms have reported ratings in the last year.
The stock price for Vir Biotechnology (NASDAQ: VIR) is $8.11 last updated April 22, 2024 at 4:51 PM EDT.
There are no upcoming dividends for Vir Biotechnology.
Vir Biotechnology’s Q1 earnings are confirmed for Thursday, May 2, 2024.
There is no upcoming split for Vir Biotechnology.
Vir Biotechnology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.